Imports
€4.9B
1.4M kg
Exports
€39.7B
5.3M kg
Balance
€34.8B
Surplus
Price/kg
€3.5K/kg
Over the Jan 2022-Mar 2026 period, the EU recorded a trade surplus of €34.8B for Vaccines for human medicine, Vaccines against SARS-related coronaviruses (SARS-CoV species) (NC8 30024110), a predominantly exported product. Exports reached €39.7B compared to €4.9B in imports. The average import price stood at €3.5K/kg.
| 1 | 🇨🇭 Switzerland | €2.4B | 49.3% |
| 2 | 🇺🇸 United States | €1.5B | 29.9% |
| 3 | 🇮🇳 India | €626.9M | 12.8% |
| 4 | 🇿🇦 South Africa | €213.4M | 4.3% |
| 5 | 🇯🇵 Japan | €122.5M | 2.5% |
| 6 | 🇬🇧 United Kingdom | €9.6M | 0.2% |
| 7 | 🇬🇹 Guatemala | €418K | 0.0% |
| # | Country | Value (EUR) | Share (%) |
|---|---|---|---|
| 1 | 🇯🇵 Japan | €9.5B | 24.0% |
| 2 | 🇺🇸 United States | €8.9B | 22.5% |
| 3 | 🇬🇧 United Kingdom | €4.1B | 10.3% |
| 4 | 🇧🇷 Brazil | €2.8B | 7.0% |
| 5 | 🇦🇺 Australia | €1.9B | 4.9% |
| 6 | 🇲🇽 Mexico | €135.7M | 0.3% |
€0
1.0B PST€0
2.5B PST+€0
€4.89/PST
(€3.5K/kg)€15.93/PST
(€7.5K/kg)3,586
ConcentratedThird-country sourcing partners
| # | Partner | Value (EUR) | kg | €/kg | Share | YoY |
|---|---|---|---|---|---|---|
| 1 | 🇨🇭 Switzerland | €2.4B | 85Kt | €28.6K/kg | 49.8% | |
| 2 | 🇺🇸 United States | €1.5B | 436Kt | €3.4K/kg | 30.2% | |
| 3 | 🇮🇳 India | €626.9M | 540Kt | €1.2K/kg | 12.9% | |
| 4 | 🇿🇦 South Africa | €213.4M | 253Kt | €843.67/kg | 4.4% | |
| 5 | 🇯🇵 Japan | €122.5M | 17Kt | €7.2K/kg | 2.5% | |
| 6 | 🇬🇧 United Kingdom | €9.6M | 623 | €15.4K/kg | 0.2% | |
| 7 | 🇬🇹 GT | €418K | 23 | €18.2K/kg | 0.0% |
Third-country target markets
| # | Partner | Value (EUR) | kg | €/kg | Share | YoY |
|---|---|---|---|---|---|---|
| 1 | 🇯🇵 Japan | €9.5B | 658Kt | €14.5K/kg | 34.7% | |
| 2 | 🇺🇸 United States | €8.9B | 2.3Mt | €3.8K/kg | 32.5% | |
| 3 | 🇬🇧 United Kingdom | €4.1B | 221Kt | €18.6K/kg | 15.0% | |
| 4 | 🇧🇷 Brazil | €2.8B | 209Kt | €13.3K/kg | 10.2% | |
| 5 | 🇦🇺 Australia | €1.9B | 140Kt | €13.9K/kg | 7.1% | |
| 6 | 🇲🇽 Mexico | €135.7M | 52Kt | €2.6K/kg | 0.5% |